drugset / Trial / NCT01977170

Safety of Hib Vaccine (Bio Farma)

NCT01977170 ↗

Phase 1 Completed 25 enrolled PT Bio Farma
NaSingle-groupOpen-labelPrevention

Summary

The objective of this study was to know the safety of Hib/PRP-T vaccine and immediate reactions within the first 30 minutes after injection.

Timeline

Start
2010-11
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Hib/PRP-T vaccine Vaccine 0.5 ml —

Indications

No indication recorded.